Pfizer shares fall despite upbeat 2018 guidance and market beating fourth quarter numbers
Pfizer expects a "meaningfully lower" effective tax rate this year and a repatriation tax liability of about US$15bn over eight years
Company
Pfizer Inc
NYSE:PFE
Pfizer Inc is a research-based biopharmaceutical company. The company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operates through two segments: Biopharma and PC1.
293 stories · page 11 of 15
Hardware & electrical equipment
Apple, Nvidia, Kohl's Corp and Pfizer - PRE-MARKET
Proactive takes a look at the pre-market deals in New York on Monday to see what's attracting interest
Darden Restaurants, Pfizer, Carnival Corp, Heico, Campbell Soup - PRE-MARKET
A look at some of the early movers in New York pre-market trade
Strong pneumonia vaccine sales help Pfizer to top Street estimates
Excluding one-off items, Pfizer earned US$0.67 a share, beating the average analyst estimate of US$0.64 per share
Geron Corporation, Pfizer, Under Armour and more - PRE-MARKET
Proactive keeps and eye on the share needle before the bell in New York
PreveCeutical Medical appoints chief scientific officer to board of directors
“[Dr Makarand Jawadekar’s] exceptional knowledge in drug delivery technologies and experience in the pharmaceutical industry will be of tremendous benefit to the company”
Archive
Lloyds Banking looking to put its trials behind it
PPI, the HBOS acquisition and now the prospect of a rate rise hitting the mortgage market; it's all a bit of a trial for Lloyds
Lloyds, Barclays and RBS under the microscope with release of third quarter earnings
The week ahead includes third quarter earnings from Lloyds, Barclays and RBS along with trading updates from Shire, IAG and GSK
US benchmarks head higher as Catalonia, Apple and Spielberg in the frame
US benchmarks were sliding towards a positive close on Tuesday
Pfizer ponders spinning off its Consumer Healthcare division
The viagra maker is considering whether it can release value by spinning off some or all of its consumer healthcare business, which includes brands such as Advil, Chapstick and Preparation H.
Pfizer, Amgen , Clovis Oncology and more - PRE-MARKET
A look at what stocks are moving the needle, up and down, before the bell in New York
Versartis shares take a dive after growth hormone deficiency treatment trial fails primary endpoint
Chief executive Jay Shepard said the company will be issuing a corporate update later this year
FDA sends damning warning letter to Pfizer after misfiring EpiPens linked to deaths
US, Food and Drug Administration, Pfizer Inc, Mylan, EpiPen, anaphylactic shock, warning letter, Meridian Medical Technologies, pharma, drugs
Pfizer receives FDA approval for acute myeloid leukemia therapy
The treatment also approved for children, two years and older with relapsed or refractory CD33-positive acute myeloid leukemia.
Pfizer quarterly revenue falls more than forecast on lower demand for Prevnar and Enbrel
Pfizer has raised its earnings guidance and expects up to 30 approvals for its pipeline of medicines over the next five years
FTSE 100 closes 51 up with engineer Rolls Royce in the driving seat
With an hour and a quarter of trading to go, the UK benchmark index was ahead 58 points at 7,430, just easing back from the afternoon peak of 7,438.90
Pfizer cuts losses on Brazil drug maker with sale for nominal sum
Generic drug makers in the country have struggled due to rising raw material costs and a prolonged recession.
Eli Lilly /Pfizer back pain treatment gets fast track status from US Food and Drug Administration
A phase III trial is currently underway and includes six studies in 7,000 patients suffering osteoarthritis, chronic low back pain and cancer.
GlaxoSmithKline makes submissions for key HIV single-tablet treatment to both the EMA and the US FDA
The submission is for a combination of dolutegravir, developed by ViiV Healthcare and Tivicay, and rilpivirine, developed by Edurant, and Janssen Sciences Ireland UC
US stocks close higher as oil price firms
President Trump and the OPEC meeting on Thursday are sure to be big themes this week